When it comes to herbal and dietary supplements, the main areas of interest to the FDA are good manufacturing practices and the New Dietary Ingredient guidelines.
What does it mean for supplement manufactures and for consumers if the FDA tightens the noose on its regulatory responsibilities?
Certain supplements do not need FDA approval before manufacturers can send them to the shelves of your grocery and health stores. However, if there is a new dietary ingredient, the product will have to be tested to ensure it's safe to the public.
New Dietary Ingredient (NDI) guidelines require manufacturers to notify the FDA regarding the identity and safety of new dietary ingredients in their products before selling them.
How are future regulations shaping the relationship between manufacturers and consumers?
Dr. Daniel Fabricant, the former FDA Director of the Division of Dietary Supplement Programs, joins Dr. Mike to discuss the impact of regulatory practices on the supplement industry.
Future Regulations of the Supplement Industry
Featured Speaker:
Dr. Daniel Fabricant is the Executive Director and CEO of the Natural Products Association (NPA), the nation's largest and oldest trade organization representing the natural products industry.
Most recently, Dr. Fabricant served as the Director of the Division of Dietary Supplement Programs at the U.S. Food and Drug Administration (FDA), where he directed all agency policy, public affairs and regulatory action regarding the dietary supplement industry.
He has a PhD in Pharmacognosy from the University of Illinois at Chicago, where he has served as an adjunct professor in the Department of Medicinal Chemistry and Pharmacognosy since 2009.
He has also published extensively and is internationally recognized for his regulatory and governmental public health expertise and natural products research.
Dr. Daniel Fabricant is the Executive Director and CEO of the Natural Products Association (NPA), the nation's largest and oldest trade organization representing the natural products industry.Most recently, Dr. Fabricant served as the Director of the Division of Dietary Supplement Programs at the U.S. Food and Drug Administration (FDA), where he directed all agency policy, public affairs and regulatory action regarding the dietary supplement industry.
He has a PhD in Pharmacognosy from the University of Illinois at Chicago, where he has served as an adjunct professor in the Department of Medicinal Chemistry and Pharmacognosy since 2009.
He has also published extensively and is internationally recognized for his regulatory and governmental public health expertise and natural products research.